Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Gas6 increases myelination by oligodendrocytes and its deficiency delays recovery following cuprizone-induced demyelination.
Laquinimod Phase IIa Study in Active Crohn's Disease
Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis.
Takeda Submits a New Drug Application for Glatiramer Acetate in Japan for the Relapse Prevention of Multiple Sclerosis
Teva Presents Data Comparing Early Treatment with COPAXONE® 40 mg/mL to Delayed Start Treatment at 67th American Academy of Neurology (AAN) Annual Meeting in Washington, D.C.
Disease-modifying treatments for progressive multiple sclerosis.
New data show positive results from Phase 4 study of Avonex Pen for treatment of RRMS patients
3D models of human ERα and ERβ complexed with coumestrol.
Comparing the biological impact of glatiramer acetate with the biological impact of a generic.
CD137 ligand activated microglia induces oligodendrocyte apoptosis via reactive oxygen species.
Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years.
Novel immunosuppressive strategies for bone marrow failure syndromes: a focus on alemtuzumab.
Role of the Blood-Brain Barrier in Multiple Sclerosis.
Effects of idebenone (CV-2619) and its metabolites on respiratory activity and lipid peroxidation in brain mitochondria from rats and dogs.
A systematic review of research undertaken in vocational rehabilitation for people with multiple sclerosis.
Accentia Biopharmaceuticals Conducts Investigator Meeting in Preparation for New Multiple Sclerosis Drug Study for Cyrevia™
The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade.
Amyloid precursor protein at node of Ranvier modulates nodal formation.
Cutaneous and pulmonary sarcoidosis following treatment of multiple sclerosis with interferon-beta-1b: a case report.
Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.
Asymptomatic lung disease caused by Mycobacterium kansasii as an opportunistic infection in a patient treated with natalizumab for relapsing-remitting multiple sclerosis.
Multiple sclerosis susceptibility genes: associations with relapse severity and recovery.
Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis.
Suppression of Murine Experimental Autoimmune Optic Neuritis by Mature Dendritic Cells Transfected with Calcitonin Gene-Related Peptide Gene.
Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma

Pages